UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients

Atherosclerosis, 2007-10, Vol.194 (2), p.e116-e122

2007

Volltextzugriff (PDF)

No Significant Effect of COVID-19 on Immunological and Virological Parameters in Patients With HIV-1 Infection

Journal of acquired immune deficiency syndromes (1999), 2020-09, Vol.85 (1), p.e6-e8

2020

Volltextzugriff (PDF)

COVID-19 Outcomes in Patients With Uncontrolled HIV-1 Infection

Journal of acquired immune deficiency syndromes (1999), 2021-01, Vol.86 (1), p.e15-e17

2021

Volltextzugriff (PDF)

COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy

Infection, 2021-04, Vol.49 (2), p.333-337

2021

Volltextzugriff (PDF)

Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir

Infection, 2020-04, Vol.48 (2), p.213-221

2020

Volltextzugriff (PDF)

Weight gain in treatment-naive HIV-1 infected patients starting abacavir/lamivudine/dolutegravir or tenofovir alafenamide/emtricitabine/bictegravir

AIDS (London), 2022-01, Vol.36 (1), p.153-155

2022

Volltextzugriff (PDF)

Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed People Living with HIV-1 Aged Over 65 Years

AIDS research and human retroviruses, 2024-02, Vol.40 (2), p.73

2024

Volltextzugriff (PDF)

Doravirine/lamivudine/tenofovir disoproxil fumarate in virologically suppressed people living with HIV: A real-life experience

International journal of STD & AIDS, 2023-12, Vol.34 (14), p.1018-1023

2023

Volltextzugriff (PDF)

Improvement in insulin sensitivity after switching from an integrase inhibitor‐based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gain

HIV medicine, 2024-08, Vol.25 (8), p.919-926

2024

Volltextzugriff (PDF)

Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients

Journal of antimicrobial chemotherapy, 2019-03, Vol.74 (3), p.731-738

2019

Volltextzugriff (PDF)

Simplification to dual therapy containing lamivudine and raltegravir or dolutegravir in HIV-infected patients on virologically suppressive antiretroviral therapy

Journal of antimicrobial chemotherapy, 2020-11, Vol.75 (11), p.3327-3333

2020

Volltextzugriff (PDF)

Reduced Admissions for Cerebrovascular Events During COVID-19 Outbreak in Italy

Stroke (1970), 2020-12, Vol.51 (12), p.3746-3750

2020

Volltextzugriff (PDF)

Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients

Journal of antimicrobial chemotherapy, 2016-06, Vol.71 (6), p.1451-1465

2016

Volltextzugriff (PDF)

Short Communication: No Significant Changes in Weight and Body Fat Mass in Suppressed HIV-Infected Patients Switched to Dual Combination Lamivudine Plus Dolutegravir or Raltegravir

AIDS research and human retroviruses, 2021-03, Vol.37 (3), p.204-206

2021

Volltextzugriff (PDF)

Short Communication: No Significant Increase in Body Fat Mass in Naive HIV-Infected Patients Starting Raltegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine

AIDS research and human retroviruses, 2021-01, Vol.37 (1), p.11-15

2021

Volltextzugriff (PDF)

Prevalence of transmitted drug resistance mutations among newly diagnosed HIV‐1‐infected patients in a large teaching hospital of the Northern Italy

Journal of medical virology, 2020-08, Vol.92 (8), p.929-931

2020

Volltextzugriff (PDF)

Rosuvastatin decreases serum inflammatory markers and slows atherosclerosis progression rate in treated HIV-infected patients with metabolic syndrome

Infectious diseases (London, England), 2021-02, Vol.53 (2), p.81-88

2021

Volltextzugriff (PDF)

Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients

AIDS (London), 2017-03, Vol.31 (5), p.681-688

2017

Volltextzugriff (PDF)

Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy

AIDS research and human retroviruses, 2017-02, Vol.33 (2), p.126-132

2017

Volltextzugriff (PDF)

Simplification to dual-therapy containing lamivudine and darunavir/ritonavir or atazanavir/ritonavir in HIV-infected patients on virologically suppressive antiretroviral therapy

Infectious diseases (London, England), 2018-05, Vol.50 (5), p.352-360

2018

Volltextzugriff (PDF)

Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz

Current HIV research, 2016-01, Vol.14 (1), p.61-70

2016

Volltextzugriff (PDF)

Factors associated with vitamin D deficiency in HIV-1 infected patients on combination antiretroviral therapy: a case-control study

The New microbiologica, 2019-07, Vol.42 (3), p.145-149

2019

Volltextzugriff (PDF)

Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study)

Infectious diseases (London, England), 2017-10, Vol.49 (10), p.737-747

2017

Volltextzugriff (PDF)

Rehabilitation needs in oncological patients: the On-rehab project results on patients operated for musculoskeletal tumors

European journal of physical and rehabilitation medicine, 2017-02, Vol.53 (1), p.81

2017

Volltextzugriff (PDF)

Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infection

International journal of infectious diseases, 2013-10, Vol.17 (10), p.e875-e882

2013

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients

No Significant Effect of COVID-19 on Immunological and Virological Parameters in Patients With HIV-1 Infection

COVID-19 Outcomes in Patients With Uncontrolled HIV-1 Infection

COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy

Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir

Weight gain in treatment-naive HIV-1 infected patients starting abacavir/lamivudine/dolutegravir or tenofovir alafenamide/emtricitabine/bictegravir

Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed People Living with HIV-1 Aged Over 65 Years

Doravirine/lamivudine/tenofovir disoproxil fumarate in virologically suppressed people living with HIV: A real-life experience

Improvement in insulin sensitivity after switching from an integrase inhibitor‐based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gain

Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients

Simplification to dual therapy containing lamivudine and raltegravir or dolutegravir in HIV-infected patients on virologically suppressive antiretroviral therapy

Reduced Admissions for Cerebrovascular Events During COVID-19 Outbreak in Italy

Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients

Short Communication: No Significant Changes in Weight and Body Fat Mass in Suppressed HIV-Infected Patients Switched to Dual Combination Lamivudine Plus Dolutegravir or Raltegravir

Short Communication: No Significant Increase in Body Fat Mass in Naive HIV-Infected Patients Starting Raltegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine

Prevalence of transmitted drug resistance mutations among newly diagnosed HIV‐1‐infected patients in a large teaching hospital of the Northern Italy

Rosuvastatin decreases serum inflammatory markers and slows atherosclerosis progression rate in treated HIV-infected patients with metabolic syndrome

Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients

Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy

Simplification to dual-therapy containing lamivudine and darunavir/ritonavir or atazanavir/ritonavir in HIV-infected patients on virologically suppressive antiretroviral therapy

Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz

Factors associated with vitamin D deficiency in HIV-1 infected patients on combination antiretroviral therapy: a case-control study

Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study)

Rehabilitation needs in oncological patients: the On-rehab project results on patients operated for musculoskeletal tumors

Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infection

Suchergebnisse filtern